Aarhus Hospital, Tage Hansens Gade
Aarhus, DK-8000, Denmark
NCT Number: NCT00269529
The study aims to compare two different kinds of pain treatment after total knee replacement (operation with artificial knee joint): 1) a large local injection in and around the knee, supplemented with injection the day after, or 2) the department's conventional pain treatment consisting of continuous nerve block in the groin.
Looking for future studies?
Notify Me0 year and older
All sexes
Interventional
Not applicable
Aarhus, DK-8000, Denmark
Postoperative pain after total knee arthroplasty is moderate to severe and can be difficult to treat. The current use of femoral nerve block by ropivacain pump for 48 hours provides considerable analgesia, but patients often experience slight motor block, inhibiting rehabilitation, and pain in the posterior part of the knee, innervated by the sciatic nerve. This study compares femoral nerve block to a new technique, where ropivacaine, ketorolac and adrenalin is used to infiltrate the tissue in and around the knee joint during surgery, and is injected by an intraarticular catheter at 10 pm on the day of surgery and again at 10 am the day after. Data of pain scores, analgesia consumption, adverse effects and mobilisation is collected for the first four postoperative days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Aarhus
Other
Postoperative Analgesia After Total Knee Arthroplasty. A Comparison of Continuous Femoral Block and Extensive Intraoperative Infiltration With Local Anesthetic Supplemented With Intraarticular Bolus the Following Day.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03411083
Agnosia, Arthroplasty, Replacement, Knee
Silkeborg, Jutland, Denmark
View Trial DetailsNCT02453360
Agnosia, Arthroplasty, Replacement, Knee
Madison, Wisconsin, United States
View Trial DetailsNCT03623230
Agnosia, Anesthesia and Analgesia
Karabağlar, İzmir, Turkey (Türkiye)
View Trial DetailsNCT07360392
Agnosia, Anesthesia, Regional
Amasya, Turkey (Türkiye)
View Trial Details